CLARIP Stock Overview
Clariane SE provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 3/6 |
Rewards
Risk Analysis
+ 1 more risk
Clariane SE Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €3.38 |
52 Week High | €9.68 |
52 Week Low | €3.38 |
Beta | 1.03 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -89.24% |
5 Year Change | -89.14% |
Change since IPO | -71.51% |
Recent News & Updates
Recent updates
Shareholder Returns
CLARIP | GB Healthcare | GB Market | |
---|---|---|---|
7D | 0% | -1.7% | 1.1% |
1Y | n/a | -30.5% | 1.9% |
Return vs Industry: Insufficient data to determine how CLARIP performed against the UK Healthcare industry.
Return vs Market: Insufficient data to determine how CLARIP performed against the UK Market.
Price Volatility
CLARIP volatility | |
---|---|
CLARIP Average Weekly Movement | n/a |
Healthcare Industry Average Movement | 7.6% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.5% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: CLARIP has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CLARIP's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | n/a | Sophie Boissard | www.clariane.com |
Clariane SE provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues. The company operates long-term care nursing homes, specialized clinics, and assisted living and shared housing facilities for seniors, as well as offers home care, support, and hospitalization services. It operates approximately health care facilities and networks in France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom.
Clariane SE Fundamentals Summary
CLARIP fundamental statistics | |
---|---|
Market cap | €228.08m |
Earnings (TTM) | €28.04m |
Revenue (TTM) | €4.74b |
8.1x
P/E Ratio0.0x
P/S RatioIs CLARIP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CLARIP income statement (TTM) | |
---|---|
Revenue | €4.74b |
Cost of Revenue | €3.30b |
Gross Profit | €1.44b |
Other Expenses | €1.41b |
Earnings | €28.04m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Feb 28, 2024
Earnings per share (EPS) | 0.26 |
Gross Margin | 30.33% |
Net Profit Margin | 0.59% |
Debt/Equity Ratio | 113.4% |
How did CLARIP perform over the long term?
See historical performance and comparison